Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma

Journal of Medical Virology

Volumn 51, Issue 1, 1997, Pages 67-79

  Jackson, Peter ^a,c   Petrik, Juraj ^a,c   Alexander, Graeme J M ^b   Pearson, Gavin ^a,c   Allain, Jean Pierre ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c East Anglia Blood Centre   (United Kingdom)

Author keywords

ELISA; epitopes; hydrophilicity; hypervariable region; immunoreactivity

Indexed keywords

CORE PROTEIN; EPITOPE; SYNTHETIC PEPTIDE; VIRUS ENVELOPE PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOREACTIVITY; VIRUS CORE; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; BLOOD DONORS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOME, VIRAL; HAPTENS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYMERASE CHAIN REACTION; SERUM ALBUMIN, BOVINE; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS;

EID: 0031035817     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199701)51:1<67::AID-JMV11>3.0.CO;2-1     Document Type: Article

References (41)

1. Chan S-W, McOmish F, Holmes EC, Dow JF, Peutherer E, Follett P, Yap PL, Simmonds P (1992): Analysis of a new hepatitis C virus type and its phylogenic relationship to existing variants. Journal of General Virology 73:1131-1141.
2. Chien DY, Choo Q-L, Tabrizi A, Kuo C, McFarland J, Berger K, Lee C, Schuster JR, Nguyen T, Moyer DL, Tong M, Furuta S, Omata M, Tegtmeier G, Alter H, Schiff E, Jeffers L, Houghton M, Kuo G (1992): Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimaeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proceedings of the National Academy of Sciences of the USA 89:10011-10015.
3. Chien DY, Choo Q-L, Ralston R, Spaete R, Tong M, Houghton M, Kuo G (1993): Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342:933.
4. Ching W-M, Wychowski C, Beach MJ, Wang H, Davies CL, Carl M, Bradley DW, Alter HJ, Feinstone SM, Shih JW-K (1992): Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. Proceedings of the National Academy of Sciences of the USA 89:3190-3194.
5. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989): Isolation of a cDNA clone derived from a blood born non-A, non-B viral hepatitis genome. Science 244:359-362.
6. Choo Q-L Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M (1991): Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences of the USA 88:2451-2455.
7. Cristiano K, Di Bisceglie AM, Hoofnagle JH, Feinstone SM (1992): Hepatitis C viral RNA in serum of patients with chronic non-A, nonB hepatitis: detection by the polymerase chain reaction using multiple primers sets. Hepatology 14:51-55.
8. Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muniz E, Martin-Vega C, Rosell M, Allende H, Vidal X, Gonzalez A, Hernandez JM, Esteban R, Guardia J (1991): High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Annals of Internal Medicine 115:443-449.
9. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M, Nagai Y (1993): Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197:659-688.
10. Hijikata M, Kato N, Oostuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K (1991): HVRs in the putative glycoprotein of hepatitis C virus. Biochemical and Biophysical Research Communications 175:220-228.
11. Hopf U, Moller B, Kuther D, Stemerowicz R, Lobeck H, Ludtke-Handjery A, Walter E, Blum HE, Roggendorf M, Deinhardt F (1990): Long term follow-up of post transfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). Journal of Hepatology 10:69-76.
12. Kato N, Sekiya H, Oostuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, Ohkoshi S, Hijikata M, Shimotohno K (1991): Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Research 22:107-123.
13. Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakagawa T, Muraiso K, Ohkoshi S, Hijikata M, Shimotonho K ( 1992a): Marked sequence diversity in the putative envelope protein of hepatitis C viruses. Virus Research 22:107-123.
14. Kato N, Ootsuyama V, Ohkoshi S, Nakazawa T, Sekiya H, Hijikata M, Shimotohno K (1992b): Characterixation of hypervariable regions in the putative envelope protein of hepatitis C virus. Biochemical and Biophysical Research Communications 189:119-127.
15. Kato N, Sekiya H, Oostuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K. (1993): Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. Journal of Virology 67:3923-3930.
16. Kato N, Oostuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M (1994): Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. Journal of Virology 68:4776-4784.
17. Kuo G, Choo Q-L, Alter HJ, Gitnick AG, Redeker G, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M (1989): An assay for circulating antibodies to a major etiological virus of non-A, non-B viral hepatitis. Science 244:362-364.
18. Kurosaki M, Enomoto N, Marumo F, Sato C (1994): Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. Virology 205:161-169.
19. Kyte J, Doolittle RA (1982): A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 157:105-132.
20. LaRosa GJ, Davide JP, Weinhold K, Waterbury JA, Profy AT, Lewis JA, Langlois AJ, Dreesman R, Boswell RN, Shadduck P, Holley LH, Karplus M, Bolognesi DP, Matthews TJ, Emini EA, Putney SD (1990): Conserved sequence and structural elements in the HIV-1 principal neutalizing determinant. Science 249:932-935.
21. Lesniewski RR, Boardway KM, Casey JM, Desai SM, Devare SG, Leung TK, Mushahwar IK (1993): Hypervariable 5′-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. Journal of Medical Virology 40:150-156.
22. Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM (1994): Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. Journal of Virology 69:5063-5073.
23. Lok ASF, Chien D, Choo Q-L, Chan T-M, Chiu EKW, Cheng IKP, Houghton M, Kuo G (1993): Antibody response to core, envelope and nonstructural hepatitis C viral antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 18:497-502.
24. Martell M, Esteban JJ, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J (1992): Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. Journal of Virology 66:3225-3229.
25. Okamoto H, Kojima M, Okada S-I, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE, Peterson DA, Ito Y, Mishiro S (1992): Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: variability and stability. Virology 190:894-899.
26. Prince AM, Brotman B, Huima T, Pascual D, Jaffrey M, Inchauspe G (1992): Immunity in hepatitis C infection. Journal of Infectious Diseases 165:438-443.
27. Ray R, Khanna A, Lagging LM, Meyer K, Choo Q-L, Ralston R, Houghton M, Becherer PR (1994): Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. Journal of Virology 68:4420-4426.
28. Richards FF, Konigsberg WH, Rosenstein RW, Varga JM (1975): On the specificity of antibodies. Science 187:130-137.
29. Sallberg M, Ruden U, Wahren B, Magnius LO (1992): Immunodominant regions within the hepatitis C virus core and putative matrix proteins. Journal of Clinical Microbiology 30:1989-1994.
30. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning: A Laboratory Manual," 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
31. Scarselli E, Cerino A, Esposito G, Silini E, Mondelli MU, Traboni C (1995) Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. Journal of Virology 60:4407-4412.
32. Sekiya H, Kato N, Ootsuyama Y, Nakazawa T, Yamauchi K, Shimotohno K (1994): Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. International Journal of Cancer 57:664-670.
33. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H (1994): Neutralising antibodies against hepatitis C virus and the emergence of neutralisation escape mutant viruses. Journal of Virology 68:1494-1500.
34. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan S-W, Chayama K, Chen DS, Choo Q-L, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Estaban JI, Fay O, Hadziyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie N, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesinck HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea MS (1994): A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
35. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, Muchmore EE, Peterson DA, Mishiro S (1993): A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein. Implication for an escape from antibody. Virology 195:297-301.
36. Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, Di Nello R, Van Boven JJP, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaasberg, W, Leentvaar-Kuypers A, Polito A, Houghton M, Lelie PN (1991) Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 337:317-319.
37. Van Doorn L-J, Capriles I, Maertens G, DeLeys R, Murray K, Kos T, Schellekens H, Quint W (1995): Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. Journal of Virology 69:773-778.
38. Weiner AJ, Geyson HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M (1992): Evidence for the immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants. Potential role in chronic HCV infections. Proceedings of the National Academy of Sciences of the USA 89:3468-3472.
39. Wolfs TFW, De Jong J-J, Van den Berg H, Tijnagel JMGH, Krone WJA, Goudsmit J (1990): Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid and continuous. Proceedings of the National Academy of Sciences of the USA 87:9938-9942.
40. Zhang Z-X, Sonnenborg A, Sallberg M (1994): Antigenic structure of the hepatitis C virus envelope 2 protein. Clinical and Experimental Immunology 98:382-387.
41. Zibert A, Schreier E, Roggendorf M (1995): Antibodies to human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653-661.